PCM
FPRX

Piermont Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Piermont Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-32,504
Closed -$1.63M – 282
2016
Q4 		$1.63M Sell
32,504
-2,215
-6% -$111K 0.37% 108
2016
Q3 		$1.82M Buy
34,719
+10,458
+43% +$549K 0.43% 92
2016
Q2 		$1M Buy
24,261
+11,787
+94% +$487K 0.26% 145
2016
Q1 		$507K Buy
+12,474
New +$507K 0.16% 139